Next generation hand-held nebulisers for aerosol drug delivery: using microfluidics to tune particle size

慢性呼吸系统疾病（哮喘、慢性阻塞性肺病）影响14%的澳大利亚人，老年人和年轻人的疾病负担更重。由于缺乏协调性和灵活性，这些患者通过传统吸入器施用药物更困难。我们提出了一项专利技术，该技术通过微流体方法改善肺部药物输送，该系统专为改善用户体验和患者监测而设计。

Chronic respiratory diseases (Asthma, COPD) affect 14% of Australians with a greater disease burden felt by elderly and young patients. These patients experience more difficulty administering medication through conventional inhalers due to a lack of coordination and dexterity. We present a patented technology which improves the pulmonary delivery of medication through a microfluidic method, within a system designed specifically to improve user experience and patient monitoring.